You have 9 free searches left this month | for more free features.

HIF-PHI

Showing 1 - 25 of 165

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Anemia in Incident Dialysis Patients Trial in Changsha (HIF-PHI, Epoetin Alfa)

Not yet recruiting
  • Anemia in Incident Dialysis Patients
  • HIF-PHI
  • Epoetin Alfa
  • Changsha, Hunan, China
    Department of Nephrology, Second Xiangya Hospital, Central South
May 20, 2021

Coronary Artery Bypass Trial in Beijing (Roxadustat, Placebo)

Recruiting
  • Coronary Artery Bypass
  • Beijing, Beijing, China
  • +1 more
Apr 18, 2022

Renal Anemia Trial in Beijing (Roxadustat)

Completed
  • Renal Anemia
  • Beijing, China
    Peking University First Hospital
Nov 24, 2021

Capabilities of Perinatal Healthcare Institutions in Federation

Completed
  • Prenatal Care
  • Referral to Centre of Higher Organizational Level
  • Tešanj, Bosnia and Herzegovina
    General Hospital Tešanj
Sep 15, 2023

Prostate Cancer, PSMA, p2PSA Trial in Shanghai (Prostate biopsy)

Recruiting
  • Prostate Cancer
  • +2 more
  • Prostate biopsy
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Apr 9, 2023

Breast Tumor Female Trial in Lyon (Phi-Bra prototype measurements)

Not yet recruiting
  • Breast Neoplasm Female
  • Phi-Bra prototype measurements
  • Lyon, France
  • +1 more
Oct 10, 2022

Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)

Recruiting
  • Anemia in Dialysis-dependent CKD Patients
  • Alexandria, Egypt
    Alexandria University
Oct 29, 2023

Unauthorized Data Access Trial in Baltimore (receiving an email)

Completed
  • Unauthorized Data Access
  • receiving an email
  • Baltimore, Maryland
    Protenus, Inc.
Feb 20, 2022

Hypoxia-induced Autophagy in the Pathogenesis of MAP

Not yet recruiting
  • Hypoxia
  • +3 more
  • HIF 1α and LC3B expression and MMP-9 level
  • (no location specified)
Apr 5, 2023

Anemia, Dialysis-Dependent Chronic Kidney Disease Trial in United States (vadadustat, epoetin alfa)

Terminated
  • Anemia
  • Dialysis-Dependent Chronic Kidney Disease
  • Bakersfield, California
  • +17 more
Feb 2, 2021

Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined

Recruiting
  • Prostate Cancer
  • PSA
  • p2PSA
  • +2 more
  • Shanghai, Shanghai, China
    Xinhua Hospital Affiliated to Shanghai Jiao Tong University Scho
May 5, 2022

NEC, Atresia, Malrotation Trial (Perfusion assessment by means of the SPY-PHI camera)

Not yet recruiting
  • NEC
  • +3 more
  • Perfusion assessment by means of the SPY-PHI camera
  • (no location specified)
Feb 3, 2023

A Research for Combination of Prostate Health Index and mpMRI

Not yet recruiting
  • Prostate Cancer
    • (no location specified)
    Dec 16, 2021

    Von Hippel-Lindau Disease Trial (68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and

    Not yet recruiting
    • Von Hippel-Lindau Disease
    • 68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and pelvis) 68Ga-NODAGA-LM3 PET/CT (exploratory)
    • (no location specified)
    Mar 30, 2023

    Normobaric Hypoxia, Hypoventilation, Normoxia Trial in Lisbon (Repeated sprint)

    Not yet recruiting
    • Normobaric Hypoxia
    • +2 more
    • Repeated sprint
    • Lisbon, Portugal
      Faculty of Human Kinetics
    Nov 10, 2023

    Polycythemia; Familial, Erythrocytosis; Familial, VHL Gene Mutation Trial (Digoxin)

    Not yet recruiting
    • Polycythemia; Familial
    • +5 more
    • (no location specified)
    Feb 2, 2022

    Solid Tumor, TNBC - Triple-Negative Breast Cancer Trial in Bengbu, Beijing (LAE005 + Afuresertib + Nab-Paclitaxel, LAE005 +

    Recruiting
    • Solid Tumor
    • TNBC - Triple-Negative Breast Cancer
    • LAE005 + Afuresertib + Nab-Paclitaxel
    • +3 more
    • Bengbu, Anhui, China
    • +1 more
    May 19, 2022

    MRI Prostate in Different Prostate Health Index (Phi) Values

    Recruiting
    • Prostate Cancer
      • Hong Kong, Hong Kong
        Prince of Wales Hospital, Chinese University of Hong Kong
      Jun 29, 2022

      HIV/AIDS and Infections Trial in France (Recombinant human mAb (bNAbs), Placebo)

      Not yet recruiting
      • HIV/AIDS and Infections
      • Recombinant human monoclonal antibody (bNAbs)
      • Placebo
      • Bobigny, France
      • +16 more
      Mar 18, 2022

      Peripheral Arterial Disease Trial in Louisville (Carnosine, Placebo)

      Completed
      • Peripheral Arterial Disease
      • Louisville, Kentucky
        University of Louisville
      Aug 3, 2022

      Predict Near Future Initiation of Bed Exit

      Terminated
      • Sleep
      • Pressure sensitive pad
      • Atlanta, Georgia
        Budd Terrace
      Sep 9, 2021

      Diabetic Foot Ulcer Trial (Deferoxamine, Placebo)

      Not yet recruiting
      • Diabetic Foot Ulcer
      • (no location specified)
      May 25, 2022

      Total Antioxidant, Total Oxidant(Tos), Hypoxia Inducible

      Not yet recruiting
      • Carbon Monoxide Exposure
      • low-flow anesthesia
      • (no location specified)
      Dec 18, 2022

      NSCLC Trial in Houston (Amivantamab, Tepotinib)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Houston, Texas
        MD Anderson Cancer Center
      Oct 9, 2023